BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36722174)

  • 1. Examining the Vietnamese Montreal cognitive assessment in healthy and moderate-to-severe traumatic brain injury populations.
    Quang H; Nguyen AL; Do C; McDonald S; Nguyen C
    Clin Neuropsychol; 2023 Jul; 37(5):1062-1077. PubMed ID: 36722174
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.
    Panwar N; Purohit D; Deo Sinha V; Joshi M
    Asian J Psychiatr; 2019 Mar; 41():60-65. PubMed ID: 30396805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural adaptation and psychometric properties of the MMSE and MoCA questionnaires in Tanzanian Swahili for a traumatic brain injury population.
    Vissoci JRN; de Oliveira LP; Gafaar T; Haglund MM; Mvungi M; Mmbaga BT; Staton CA
    BMC Neurol; 2019 Apr; 19(1):57. PubMed ID: 30961532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing cognitive decline in Vietnamese older adults using the Montreal Cognitive Assessment-Basic (MoCA-B) and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) during the COVID-19 pandemic: A feasibility study.
    Nguyen TT; Hoang CBD; Hoang Le MD; Anh Vo NT; Quang H; Nguyen CM; Goodman C; Savva GM; Pham VL; Tran TT; Vo VT; Thanh Huong Ha T
    Clin Neuropsychol; 2023 Jul; 37(5):1043-1061. PubMed ID: 36999216
    [No Abstract]   [Full Text] [Related]  

  • 6. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of the Saint Louis University Mental Status examination (SLUMS) for the assessment of cognition in moderate to severe traumatic brain injury patients.
    Wu Y; Wang Y; Zhang Y; Yuan X; Gao X
    Appl Neuropsychol Adult; 2023; 30(4):409-413. PubMed ID: 34372718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the validity and reliability of the Chinese version of the Saint Louis University Mental Status Examination (SLUMS) in detecting cognitive impairment in patients with traumatic brain injury.
    Zhang S; Wu YH; Zhang Y; Zhang Y; Cheng Y
    Appl Neuropsychol Adult; 2021; 28(6):633-640. PubMed ID: 31646902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool.
    Novak A; Vizjak K; Gacnik A; Rakusa M
    Acta Neurol Belg; 2023 Apr; 123(2):451-456. PubMed ID: 35925540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Gomez-Moreno SM; Cuadrado ML; Cruz-Orduña I; Martínez-Acebes EM; Gordo-Mañas R; Fernández-Pérez C; García-Ramos R
    Neurologia (Engl Ed); 2022; 37(9):726-734. PubMed ID: 34836843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke.
    Potocnik J; Ovcar Stante K; Rakusa M
    Acta Neurol Belg; 2020 Jun; 120(3):681-685. PubMed ID: 32193731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
    Yu J; Li J; Huang X
    BMC Psychiatry; 2012 Sep; 12():156. PubMed ID: 23009126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of the Rowland Universal Dementia Assessment Scale for patients with traumatic brain injury.
    Cheng Y; Zhang Y; Zhang Y; Wu YH; Zhang S
    Appl Neuropsychol Adult; 2022; 29(5):1160-1166. PubMed ID: 33321049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Validity of the Montreal Cognitive Assessment for Moderate to Severe Traumatic Brain Injury Patients: A Pilot Study.
    Tay MRJ; Soh YM; Plunkett TK; Ong PL; Huang W; Kong KH
    Am J Phys Med Rehabil; 2019 Nov; 98(11):971-975. PubMed ID: 31136306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment.
    Thomann AE; Berres M; Goettel N; Steiner LA; Monsch AU
    Alzheimers Res Ther; 2020 Apr; 12(1):39. PubMed ID: 32264975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.